Listen to Gynecologic Oncology
50 episodes - English - Latest episode: 15 days ago -Listen to the latest news from the experts in your field.
Homepage Google Podcasts Overcast Castro Pocket Casts RSS feed
Episodes
Editor's Choice: SENTIREC-endo study: Is the juice worth the squeeze?
April 15, 2024 12:00 - 13 minutesEditor’s Choice Paper: Identifying safe diagnostic algorithms for sentinel lymph node mapping in high-risk endometrial cancer: The SENTIREC-endo study Editorial: Sentinel lymph node biopsy in high-risk endometrial cancer: The dénouement Hosted by: Gregg Nelson, MD, Social Media Editor of Gynecologic Oncology Featuring: Sarah M. Bjørnholt, MD, Aarhus University Hospital, Denmark Sean Dowdy, MD, Mayo Clinic, USA
Editor's Choice: Caring for the Caregiver
April 04, 2024 12:00 - 19 minutesEditor’s Choice Paper: Experiences of patients with peritoneal carcinomatosis-related complex care needs and their caregivers Editorial: The importance of family-focused care in the setting of advanced gynecological cancers Hosted by: Sean Dowdy, MD, Associate Editor of Gynecologic Oncology Featuring: Rachel A. Pozzar, PhD, RN, Dana Farber Cancer Institute and Harvard Medical School Allison J. Applebaum, PhD, Caregivers Clinic, Memorial Sloan Kettering Cancer Center
Editor’s Choice: Lunchbox Trial
February 29, 2024 12:00 - 10 minutesEditor’s Choice Paper: Lunchbox trial: A randomized phase III trial of cisplatin and irradiation followed by carboplatin and paclitaxel versus sandwich therapy of carboplatin and paclitaxel followed by irradiation then carboplatin and paclitaxel for advanced endometrial carcinoma Editorial: What's in your “lunchbox”? Sandwich versus sequential chemotherapy and irradiation for advanced endometrial cancer Hosted by: Ursula Matulonis, MD, Associate Editor of Gynecologic Oncology Featuring:...
Editor’s Choice: Optimization of endometrial cancer survivorship through modification of lifestyle factors
January 29, 2024 12:00 - 10 minutesEditor’s Choice Paper: Associations between modifiable lifestyle factors and health-related quality of life among endometrial carcinoma survivors - A cross-sectional study Hosted by: Gregg Nelson, MD, PhD, Social Media Editor of Gynecologic Oncology Featuring: Ane Gerda Z. Eriksson, MD, Oslo University Hospital, Norway S. J. Kitson, MD, University of Manchester, UK
Editor’s Choice: Engagement with ERAS patients leads to improved outcomes
January 29, 2024 12:00 - 10 minutesEditor’s Choice Paper: Use of a mobile health patient engagement technology improves perioperative outcomes in gynecologic oncology patients Editorial: How does mobile health engagement technology help gynecologic oncology patients recover from surgery, affect health equity, and impact healthcare costs? Hosted by: Gregg Nelson, MD, PhD, Social Media Editor of Gynecologic Oncology Featuring: Teresa K.L. Boitano, MD, University of Alabama at Birmingham Kevin M. Elias, MD, FACOG, FACS, Bri...
October 2023 Editor’s Choice: OS updates for Imagyn50
November 17, 2023 12:00 - 14 minutesEditor’s Choice Paper: Overall survival and patient-reported outcome results from the placebo-controlled randomized phase III IMagyn050/GOG 3015/ENGOT-OV39 trial of atezolizumab for newly diagnosed stage III/IV ovarian cancer Hosted by: Ursula Matulonis, MD, Associate Editor of Gynecologic Oncology Featuring: Kathleen N. Moore, MD, GOG-F and Stephenson Cancer Center at the University of Oklahoma Health Sciences Center
September 2023 Editor’s Choice: Is now the time to begin thromboprophylaxis for all patients with advanced ovarian cancer, including those undergoing neoadjuvant chemotherapy?
October 27, 2023 12:00 - 16 minutesEditor’s Choice Paper: Incidence of venous thromboembolism in patients with advanced stage ovarian cancer undergoing neoadjuvant chemotherapy: Is it time for thromboprophylaxis? Editorial: Universal thromboprophylaxis in ovarian cancer patients before and after surgery? Hosted by: David E. Cohn, MD, MBA, FACHE, Editor-in-Chief of Gynecologic Oncology Featuring: Amanika Kumar, MD, Mayo Clinic Laura Havrilesky, MD, Duke University
August 2023 Editor’s Choice: What is your center doing to improve genetic testing following abnormal MMR results in endometrial cancer?
September 28, 2023 12:00 - 19 minutesEditor’s Choice Papers: Improving genetic testing following abnormal mismatch repair immunohistochemistry results in endometrial cancer Editorial: Universal testing – Should it be that hard? Probably. If you're doing it right Hosted by: Gregg Nelson, MD, PhD, Social Media Editor of Gynecologic Oncology Featuring: Bhavana Pothuri, MD,NYU Perlmutter Cancer Center Leigha Senter, MS, CGC, The Ohio State University College of Medicine
July 2023 Editor’s Choice: The evolution of patient-centered endometrial cancer detection: testing tompon-based collection for methylated DNA markers
August 16, 2023 19:30 - 28 minutesEditor’s Choice Papers: Detection of endometrial cancer using tampon-based collection and methylated DNA markers Editorial: Early detection of endometrial cancer Hosted by: Dineo Khabele, MD, Associate Editor of Gynecologic Oncology Featuring: Jamie N. Bakkum-Gamez, MD, Mayo Clinic Jonathan C. Dudley, MD, The Johns Hopkins University School of Medicine
TKI Toxicities: A Society of Gynecologic Oncology Podcast
July 10, 2023 19:30 - 25 minutesTKI Toxicities: A Society of Gynecologic Oncology Podcast Moderator: Róisín O’Cearbhaill, MD, Gynecologic Medical Oncologist, Memorial Sloan Kettering Cancer Center, New York Speakers: BJ Rimel, MD, Gynecologic Oncologist, Cedars-Sinai Medical Center Erin Crane, MD, MPH, Gynecologic Oncologist, Levine Cancer Institute Vicky Makker, MD, Medical Oncologist, Memorial Sloan Kettering Cancer Center Jennifer MacDonald, PharmD, Oncology Clinical Pharmacy Specialist, Medical University of Sout...
June 2023 Editor's Choice: ERAS Society Updates: What Every Gyn Oncologist Should Know
July 01, 2023 19:30 - 27 minutesEditor’s Choice Papers: Enhanced recovery after surgery (ERAS reg) society guidelines for gynecologic oncology: Addressing implementation challenges - 2023 update Editorial: Gynecologic oncology surgery – Ready for the next step in ERAS Hosted by: Amanda Nickles Fader, MD, Associate Editor of Gynecologic Oncology Featuring: Gregg Nelson, MD, University of Calgary Sean Dowdy, MD, Mayo Clinic College of Medicine Olle Ljungqvist, MD, Orebro University Hospital
April 2023 Editor’s Choice: The times they are a changin’ – the future of the specialty
May 12, 2023 09:00 - 20 minutesEditor’s Choice Papers: Doubling down on the future of gynecologic oncology: The SGO future of the profession summit report Editorial: “The times they are a-changin’” – And how are we managing? Hosted by: David E. Cohn, MD, MBA, FACHE, Editor-in-Chief of Gynecologic Oncology Featuring: Stephanie V. Blank,MD, Icahn School of Medicine at Mount Sinai Warner K. Huh, MD, FACOG, FACS, University of Alabama Birmingham
March 2023 Editor’s Choice: Intrathoracic Surgery and Ovarian Cancer Cytoreduction: Why the Chest Matters
April 11, 2023 05:15 - 26 minutesEditor’s Choice Papers: Intrathoracic surgery as part of primary cytoreduction for advanced ovarian cancer: Going to the next level – A Memorial Sloan Kettering Cancer Center study Editorial: Intrathoracic surgery as part of primary cytoreduction for advanced ovarian cancer: The evolution of a “pelvic” surgeon Hosted by: Warner K. Huh, MD, FACOG, FACS, Deputy Editor of Gynecologic Oncology Featuring: Ryan M. Kahn MD,FACOG, Memorial Sloan Kettering Cancer Center Dennis Chi, MD, Me...
February 2023 Editor’s Choice: A Geo-Analyzer Tool that assessed insured patients in your metropolitan area with recurrent and metastatic cervix cancer
February 02, 2023 05:15Hosted by: Wendy R. Brewster, MD, PhD, Deputy Editor of Gynecologic Oncology Featuring: Turgay Ayer, Georgia Institute of Technology Tara Castellano, MD, Louisiana State University HSC Isabel C. Scarinci, PhD, MPH, University of Alabama at Birmingham Editor’s Choice Paper: Cervical cancer geographical burden analyzer: An interactive, open-access tool for understanding geographical disease burden in patients with recurrent or metastatic cervical cancer Editorial: Targeting our efforts: ...
Molecular Testing for Endometrial Cancer: A Society of Gynecologic Oncology Podcast
January 05, 2023 05:15Moderator: Kari Hacker, MD, PhD, Gynecologic Oncologist, New York University Langone Health Speakers: Christine Walsh, MD, MS, Gynecologic Oncologist, University of Colorado Carolyn McCourt, MD, Gynecologic Oncologist, Washington University School of Medicine Kari Hacker, MD, PhD, is joined by Christine Walsh, MD, MS, and Carolyn McCourt, MD, to review basic molecular classification as well as more complex biomarkers in endometrial cancer. They discuss how testing can be utilized to info...
January 2023 Editor’s Choice: Sentinel lymph node mapping in endometrial complex atypical hyperplasia: good idea or have we gone too far?
January 05, 2023 05:15Editor’s Choice Papers: Sentinel lymph node mapping in patients with endometrial hyperplasia: A practice to preserve or abandon? Is sentinel lymph node assessment useful in patients with a preoperative diagnosis of endometrial intraepithelial neoplasia? Editorial: Routine SLN biopsy for endometrial intraepithelial neoplasia: A pragmatic approach or over-treatment? Hosted by: Gregg Nelson, MD, PhD, Social Media Editor of Gynecologic Oncology Featuring: Jennifer Mueller MD, Memoria...
Burnout and gynecologic oncology - does the problem still exist?
January 05, 2023 05:15Hosted by: Gregg Nelson, MD, PhD, Social Media Editor of Gynecologic Oncology Featuring: Brittany A. Davidson, MD, Duke University David M. Kushner, MD, UW School of Medicine and Public Health Article: SGO and the elephant that is still in the room: Wellness, burnout and gynecologic oncology
December 2022 Editor’s Choice: Exceptional PARP inhibitor responders: the good and the bad
December 29, 2022 05:15Hosted by: Ursula Matulonis, MD, Associate Editor of Gynecologic Oncology and Author of the editorial Featuring: David O'Malley, MD, The Ohio State University Editor’s Choice Paper: Clinical and molecular characteristics of ARIEL3 patients who derived exceptional benefit from rucaparib maintenance treatment for high-grade ovarian carcinoma Editorial: The rapid evolution of PARP inhibitor therapy for advanced ovarian cancer: Lessons being learned and new questions emerging from phase ...
Burnout and gynecologic oncology — does the problem still exist?
December 23, 2022 17:00 - 23 minutes - 31.3 MBHosted by: Gregg Nelson, MD, PhD, Social Media Editor of Gynecologic Oncology Featuring: Brittany A. Davidson, MD, Duke University, David M. Kushner, MD, UW School of Medicine and Public Health Article: SGO and the elephant that is still in the room: Wellness, burnout and gynecologic oncology
November 2022 Editor’s Choice: Management of primary low-grade serous ovarian carcinoma: are you up-to-date on the most contemporary prognostic factors and treatment strategies?
November 03, 2022 05:15Hosted by: Amanda Nickles Fader, MD, Associate Editor of Gynecologic Oncology Featuring: David M. Gershenson, MD, The University of Texas MD Anderson Cancer Center Charlie Gourley, MD, Nicola Murray Centre for Ovarian Cancer Research Editor’s Choice Paper: Contemporary primary treatment of women with stage II-IV low-grade serous ovarian/peritoneal cancer (LGSOC): Determinants of relapse and disease-free survival Editorial: Low grade serous ovarian cancer: Unpicking drivers of outcome
October 2022 Editor’s Choice: How do you manage the contralateral groin in early stage vulvar cancer with a unilateral positive sentinel lymph node?
October 06, 2022 05:15Hosted by: S. Diane Yamada, MD, Deputy Editor of Gynecologic Oncology Featuring: Maaike Oonk, MD, University Medical Center Groningen, University of Groningen, The Netherlands Akila Viswanathan, MD, MPH, Johns Hopkins Medicine Editor’s Choice Paper: Unilateral inguinofemoral lymphadenectomy in patients with early-stage vulvar squamous cell carcinoma and a unilateral metastatic sentinel lymph node is safe Editorial: When is it safe to omit contralateral groin management in unilateral sent...
September 2022 Editor’s Choice: Frailty assessment in gynecologic oncology - have you incorporated this into your practice?
September 28, 2022 17:00 - 16 minutes - 24.7 MBHosted by: Gregg Nelson, MD, PhD, Social Media Editor of Gynecologic Oncology Featuring: Mariam M. AlHilli, MD Gynecologic Oncologist, Cleveland Clinic, Cleveland Ohio Amanika Kumar, MD, Mayo Clinic Division of Gynecologic Surgery, Rochester, Minnesota Editor’s Choice Paper: Preoperative assessment using the five-factor modified frailty index: A call for standardized preoperative assessment and prehabilitation services in gynecologic oncology Editorial: Answering the call: Are we ready f...
August 2022 Editor’s Choice: Financial toxicity – the other side effect of cancer care
September 09, 2022 17:00 - 14 minutes - 24.7 MBHosted by: David E. Cohn, MD, MBA, FACHE, Editor-in-Chief of Gynecologic Oncology Featuring: Joshua G. Cohen, MD, Gynecologic Oncologist, City of Hope Orange County Fumiko Chino, MD, Affordability Working Group, Radiation Oncologist, Memorial Sloan Kettering Cancer Center Editor’s Choice Paper: Insurance-based disparities and risk of financial toxicity among patients undergoing gynecologic cancer operations Editorial: Financial toxicity of surgical treatment for gynecological cancer: A gr...
September 2022 Editor’s Choice: Frailty assessment in gynecologic oncology - have you incorporated this into your practice?
September 08, 2022 05:15Hosted by: Gregg Nelson, MD, PhD, Social Media Editor of Gynecologic Oncology Featuring: Mariam M. AlHilli, MD Gynecologic Oncologist, Cleveland Clinic, Cleveland, Ohio Amanika Kumar, MD, Mayo Clinic Division of Gynecologic Surgery, Rochester, Minnesota Editor’s Choice Paper: Preoperative assessment using the five-factor modified frailty index: A call for standardized preoperative assessment and prehabilitation services in gynecologic oncology Editorial: Answering the call: Are we re...
July 2022 Editor’s Choice: Complications after cytoreductive surgery and its impact on survival: where do we go from here?
August 05, 2022 17:00 - 18 minutes - 24.7 MBHosted by: Warner K. Huh, MD, FACOG, FACS, Deputy Editor of Gynecologic Oncology Featuring: Pr Alejandra Martinez, Institut Universitaire du Cancer de Toulouse Oncopole Jill Tseng, MD, UC Irvine Health Editor’s Choice Paper: The effect of major postoperative complications on recurrence and long-term survival after cytoreductive surgery for ovarian cancer Editorial: Complications associated with cytoreductive surgery for advanced ovarian cancer: Surgical timing and surmounting obstacles
July 2022 Editor’s Choice: Complications after cytoreductive surgery and its impact on survival: where do we go from here?
July 07, 2022 05:15Hosted by: Warner K. Huh, MD, FACOG, FACS, Deputy Editor of Gynecologic Oncology Featuring: Pr Alejandra Martinez, Institut Universitaire du Cancer de Toulouse Oncopole Jill Tseng, MD, UC Irvine Health Editor’s Choice Paper: The effect of major postoperative complications on recurrence and long-term survival after cytoreductive surgery for ovarian cancer Editorial: Complications associated with cytoreductive surgery for advanced ovarian cancer: Surgical timing and surmounting obstacles
May 2022 Editor’s Choice: The ProMisE of molecular classification to standardize care in endometrial cancer
June 09, 2022 17:00 - 17 minutes - 24.7 MBHosted by: S. Diane Yamada, MD, Deputy Editor of Gynecologic Oncology Featuring: Jessica N. McAlpine, MD, University of British Columbia G. Larry Maxwell, MD, FACOG, COL(ret) USA, Inova Health System Editor’s Choice Paper: Variation in practice in endometrial cancer and potential for improved care and equity through molecular classification Editorial: The ProMisE of uniform care for endometrial cancer patients
June 2022 Editor’s Choice: Long-term cardiovascular complications among gynecologic cancer survivors
June 09, 2022 05:15Hosted by: Jose Alejandro Rauh-Hain, MD, MPH, Associate Editor of Gynecologic Oncology Featuring: Steven S. Coughlin, MD, Augusta University Daniel Addison, MD, The Ohio State University Wexner Medical Center Editor’s Choice Paper: Cardiovascular conditions and obesity among gynecologic cancer survivors: Results from the 2020 behavioral risk factor surveillance system survey Editorial: The intersection of gynecologic cancer, obesity, and cardiovascular disease
Immunotherapy Toxicities: A Society of Gynecologic Oncology Podcast
June 09, 2022 05:15Moderator: Leslie Clark, MD, Gynecologic Oncologist, University of North Carolina in Chapel Hill Speakers: Róisín O’Cearbhaill, MD, Medical Oncologist, Memorial Sloan Kettering Cancer Center Ramez Eskander, MD, Gynecologic Oncologist, University of California San Diego Description: Dr. Leslie Clark presents a patient case to frame a discussion on the management of immunotherapy-related toxicities in gynecologic cancers. Drs. Róisín O’Cearbhaill and Ramez Eskander provide clinical man...
March 2022 Editor’s Choice: HRD: Improving QOL for patients with cervical cancer: SLN biopsy
April 19, 2022 17:00 - 18 minutes - 24.7 MBHosted by: Sean C. Dowdy, MD, Associate Editor of Gynecologic Oncology Featuring: Sara Elisabeth Sponholtz, MD, PhD, University of Southern Denmark Mario M. Leitao, Jr., MD, Memorial Sloan-Kettering Cancer Center Editor’s Choice Paper: SENTIREC - The sentinel node mapping in women with cervical cancer study - Patient-reported early lymphedema and its impact on quality of life Editorial: The end of routine lymphadenectomy for the treatment of cervical cancer is rapidly approaching
April 2022 Editor’s Choice: Reducing non-surgical readmissions in gynecologic oncology
April 07, 2022 05:15Hosted by: John Farley, MD, Associate Editor of Gynecologic Oncology Featuring: Catherine H. Watson, MD, Vanderbilt University Medical Center Larissa Alejandra Meyer, MD MPH, The University of Texas MD Anderson Cancer Center Editor’s Choice Paper: Reducing non-surgical readmissions on a gynecologic oncology service Editorial: Our dual responsibility of improving quality and questioning the metrics: Reflections on 30-day readmission rate as a quality indicator
March 2022 Editor’s Choice: Improving QOL for patients with cervical cancer: SLN biopsy
March 03, 2022 05:15Hosted by: Sean C. Dowdy, MD, Associate Editor of Gynecologic Oncology Featuring: Sara Elisabeth Sponholtz, MD, PhD, University of Southern Denmark Mario M. Leitao, Jr., MD, Memorial Sloan-Kettering Cancer Center Editor’s Choice Paper: SENTIREC – The sentinel node mapping in women with cervical cancer study – Patient-reported early lymphedema and its impact on quality of life Editorial: The end of routine lymphadenectomy for the treatment of cervical cancer is rapidly approaching
February 2022 Editor’s Choice: HRD: What does it really mean and are we looking at this the right way?
February 03, 2022 05:15Hosted by: Warner K. Huh, MD, FACOG, FACS, Deputy Editor of Gynecologic Oncology Featuring: Elizabeth Swisher, MD, UW Medicine Jonathan A Ledermann, MD FRCP FMedSci Professor of Medical Oncology, UCL Cancer Institute Editor’s Choice Paper: Impact of homologous recombination status and responses with veliparib combined with first-line chemotherapy in ovarian cancer in the Phase 3 VELIA/GOG-3005 study Editorial: Testing for homologous recombination deficiency – does it provide new...
January 2022 Editor’s Choice: Optimizing Rural Ovarian Cancer Care
January 06, 2022 05:15Hosted by: David E. Cohn, MD, MBA, FACHE, Editor-in-Chief of Gynecologic Oncology Featuring: Kristin Weeks, MD/PhD candidate, University of Iowa David Shalowitz , MD, MSHP, Wake Forest School of Medicine Editor’s Choice Paper: Gynecologic oncologist impact on adjuvant chemotherapy care for stage II-IV ovarian cancer patients Editorial: Defining the essential role of the gynecologic oncologist in rural ovarian cancer care delivery
December 2021: Recurrent Endometrial Cancer: A Society of Gynecologic Oncology Podcast
December 09, 2021 05:15 - 33 minutesModerator: Floor Backes, MD, Gynecologic Oncologist, The Ohio State University Comprehensive Cancer Center Speakers: Vicky Makker, MD, Medical Oncologist, Memorial Sloan Kettering Cancer Center Matthew Powell, MD, Gynecologic Oncologist and Chief, Division of Gynecologic Oncology, Washington University School of Medicine Siteman Cancer Center Amanda Nickles Fader, MD, Gynecologic Oncologist and Professor, Johns Hopkins School of Medicine Description: Dr. Floor Backes is joined by...
Looking Back at 2021: November Editor’s Choice
November 04, 2021 05:15Hosted by: Anil K. Sood, MD, MD Anderson Cancer Center Featuring: Tilley Jenkins Vogel, MD, Northshore University HealthSystem Shannon N. Westin , MD, MPH, UT MD Anderson Cancer Center Editor’s Choice Paper: Outcomes after targeted treatment based on somatic tumor genetic testing for women with gynecologic cancers Editorial: Next generation sequencing for gynecologic malignancy: Promise and potential pitfalls
April 2021: Differences in cervical cancer screening and follow-up for black and white women in the United States
April 08, 2021 05:15 - 14 minutesHost: Barbara Goff: Deputy Editor, Gynecologic Oncology and Gynecologic Oncology Reports Featuring: Sabrina Ford & Sandra Brooks
March 2021: The Future Of Gynecologic Oncology: We are at a Crossroads
March 04, 2021 05:15 - 33 minutesHost: David E. Cohn, MD, MBA, President, Society of Gynecologic Oncology, Deputy Editor Gynecologic Oncology Guest: Warner K. Huh, MD; Immediate Past-President, Society of Gynecologic Oncology
April 2020: 2020 Rare Tumors and Conditions
October 08, 2020 10:00Paper: Rare Gynecologic Tumors: Coming of Age Hosted by: Dr. Laurel Rice, Associate Editor Featuring: Dr. David Gershenson, Unveristy of Texas
August 2020: 2020 Virtual Annual SGO Meeting Report
August 12, 2020 08:45 - 20 minutesPaper: The 2020 SGO Annual Meeting Report Hosted by: Dr. Warner Huh, Immediate Past President of SGO Featuring: Dr. Kenneth Kim, Scientific Program Co-Chair, 2020 Virtual Annual SGO Meeting Dr. Kathleen Moore, Scientific Program Co-Chair, 2020 Virtual Annual SGO Meeting
PARP Inhibitor Maintenance Therapy after Initial Chemotherapy for Advanced Ovary, Fallopian Tube and Primary Peritoneal Cancers
May 23, 2020 16:00 - 26 minutesHosted by: Dr. Deborah K. Armstrong Featuring: Dr. Eskander, Dr. O’Cearbhaill, Dr. Pothuri Continuing education (CE)—0.5 credits—is available through SGO ConnectEd Link: https://sgo.peachnewmedia.com/store/seminar/seminar.php?seminar=156603 CE description: The Society of Gynecology Oncology designates this live activity for a maximum of 0.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation on each activity.
Special Topics: Present and Future Impact of COVID-19 on the Practice and Delivery on Gynecologic Oncology Care
March 26, 2020 19:00 - 32 minutesBasic Advice when dealing with COVID-19 Moderator: Warner K. Huh, MD, 2019-2020 SGO President, University of Alabama at Birmingham Guest: Elizabeth M. Swisher, MD, University of Washington (UW) Medicine, Seattle
February 2020 Editor's Choice: Financial hardship among gynecologic cancer patients
February 26, 2020 11:00 - 18 minutesEditor's Choice Paper: Extensive financial hardship among gynecologic cancer patients starting a new line of therapy Editorial Paper: Financial toxicity: An adverse effect worth of a black box warning? Hosted by: Dr. Beth Karlan, Editor-In-Chief Featuring: Dr. Karlan, Dr. Liang, Dr. Rauh-Hain
January 2020 Editor’s Choice - Does the transcriptome of ovarian neoplasms provide insight into its potential behavior?
January 30, 2020 20:00Editor's Choice Paper: Genomic heterogeneity in peritoneal implants: A differential analysis of gene expression using nanostring Human Cancer Reference panel identifies a malignant signature Editorial Paper: Not All Peritoneal Implants Are Created Equal Hosted by: Dr. David Cohn, Deputy Editor Featuring: Dr. Cohn, Dr. Fauceglia, Dr. Shih
January 2020 Editor's Choice - Does the transcriptome of ovarian neoplasms provide insight into its potential behavior?
January 30, 2020 17:00 - 19 minutes - 17.4 MBEditor's Choice Paper: "Genomic heterogeneity in peritoneal implants: A differential analysis of gene expression using nanostring Human Cancer Reference panel identifies a malignant signature" and Editorial Paper: "Not All Peritoneal Implants Are Created Equal" Hosted by: Dr. David Cohn, Deputy Editor and Featuring: Dr. Cohn, Dr. Fauceglia, Dr. Shih
December 2019 Editor's Choice
December 24, 2019 17:00 - 16 minutesEditor's Choice Paper: A phase II randomized, double-blind trial of a polyvalent Vaccine-KLH conjugate (NSC 748933 IND# 14384) + OPT-821 versus OPT-821 in patients with epithelial ovarian, fallopian tube, or peritoneal cancer who are in second or third complete remission: An NRG Oncology/GOG study Editorial Paper: Sunset, or dawn of a new age for ovarian cancer vaccine therapy? Hosted by: Dr. Barbara Goff, Deputy Editor Featuring: Dr. O'Cearbhaill, Dr. Jazaeri, Dr. Goff
November 2019 Editor's Choice - Survival of endometrial cancer patients following lymphadenectomy or sentinel node procedure
December 10, 2019 17:00 - 22 minutes - 20.8 MBEditor's Choice Paper: "Role of lymphadenectomy in endometrial cancer with nonbulky lymph node metastasis: Comparison of comprehensive surgical staging and sentinel lymph node algorithm" and Editorial Paper: "Enough already: Is this the end of comprehensive lymphadenectomy in endometrial cancer or are further trials needed?" Hosted by: Dr. Stephen Rubin, Deputy Editor and Featuring: Dr. Rubin, Dr. Mariani, Dr. Fader
November 2019 Editor’s Choice - Survival of endometrial cancer patients following lymphadenectomy or sentinel node procedure
November 30, 2019 08:00Editor's Choice Paper: Role of lymphadenectomy in endometrial cancer with nonbulky lymph node metastasis: Comparison of comprehensive surgical staging and sentinel lymph node algorithm Editorial Paper: Enough already: Is this the end of comprehensive lymphadenectomy in endometrial cancer or are further trials needed? Hosted by: Dr. Stephen Rubin, Deputy Editor Featuring: Dr. Rubin, Dr. Mariani, Dr. Fader
Inaugural Gynecologic Oncology Podcast - When to stop hCG surveillance following chemotherapy for gastational trophoblastic neoplasia
November 04, 2019 01:00 - 16 minutesEditor's Choice Paper: When to stop human chorionic gonadotrophin (hCG) surveillance after treatment with chemotherapy for gestational trophoblastic neoplasia (GTN): A national analysis on over 4,000 patients Editorial Paper: Continued hCG surveillance following chemotherapy for gestational trophoblastic neoplasia: When is enough enough? Hosted by: Dr. Beth Karlan, Editor-in-Chief Featuring: Dr. Berkowitz, Dr. Karlan, Professor Seckl